The intestinal immune system has the challenging task of tolerating foreign nutrients and the commensal 
7
the small intestine ( Fig. 1 a-c) . In germ-free (GF) mice, duodenal absorption may compensate for lack of microbiome-8 mediated distal nutrient release 11 , and this was reflected in the length of lymphatic lacteals (Fig. 1c) . In contrast, the 9 lymphatics of the colon are organized in two distinct layers, lack lacteals and did not appear to differ in GF mice,
10
suggesting that its structural organization is independent of the microbiome (Fig. 1c) . The cleared-tissue visualization 11 also revealed a seemingly continuous submucosal lymphatic network along the intestine (Fig. 1a- , following intra-gastric 21 delivery. Indeed, most retinol was absorbed in the duodenum, and this was mirrored in the D-mLNs. This was 22 dependent on the lymphatic route, as treatment with a chylomicron formation inhibitor prevented duodenal retinol 23 efflux to its draining mLN Extended Data Fig. 1f, g) . Similarly, the increased duodenal but decreased ileal 24 absorptive capacity in GF mice was displayed by corresponding retinol retention in gut tissue and mLNs (Extended
25
Data Fig. 1h -j). These data suggest that the compartmentalized lymphatic route transmits distinct niches along the 26 intestine to discrete secondary lymphoid organs, potentially contributing to a regionally-organized immune response.
28
We asked if gut segment-specific lymphatic drainage influences immune cells in the mLNs, particularly migratory tolerogenic and pro-inflammatory responses, respectively 13, 14 . We sorted these two populations from D, I and C- (Fig. 2c, d ). An enzymatic activity assay confirmed that RA production capacity of DCs was overall 8 higher in the small than in the large intestine-draining mLN DCs, and preserved in CD103 
14
Since migratory DCs play a pivotal role in instructing adaptive immune cells, we next investigated if CD4 + T cell
15
fates also differed between mLNs and correlated with migratory-DC profiles or with the presence of the microbiota.
16
Although GF mice harbour reduced Treg cells in the small and large intestines 17, 18 , there was no difference in Treg
17
cell frequency between mLNs of GF and SPF mice or along the mLN chain (Extended Data Fig. 2f-h 14 . We observed that in GF mice only the D-mLNs retained OT-II cells equally to SPF mice, while OT-II 24 frequencies were much lower in J and I and almost undetectable in C-draining mLNs (Extended Data Fig. 2k ). This
25
was paralleled by a decreased absorption of OVA into the distal gut and its draining mLNs in GF versus SPF mice
26
(Extended Data Fig. 2l -n) and mirrored the altered lymphatic structure in GF mice (Fig. 1c) , suggesting that a gradient
27
of antigen availability dictated OT-II cell frequencies in mLNs. Amongst the retained OT-II cells, we observed a 28 clear gradient of pTreg induction that declined in a proximal to distal manner (Fig. 2g, h ). In GF mice, pTreg induction
29
was decreased in all mLNs (Fig. 2g, h ), but not due to lack of activation per se (Extended Data 2o, p), suggesting the 30 less favourable DC composition in GF mLNs contributed to this effect. Limited antigen availability alone was also 31 unlikely to explain the gradient of OT-II pTreg cells in SPF mice, as CD25 + frequencies did not differ between mLNs
32
(Extended Data Fig. 2p ), and rather suggested compartmentalized difference in lymphatic retinol absorption and DC
33
expression profiles as underlying causes. In support of such a role of a local environment, OT-II RORγt + TH and
34
RORγt + pTreg cells displayed an ascending proximal to distal gradient that was independent of the microbiota ( . We fed OVA at day 6 and 7 25 post-S.v. infection and subjected mice to the asthma model of oral tolerance post-pathogen clearance (Fig. 3k ). Oral
26
tolerance is a very robust mechanism 14 , but nonetheless we observed a partial impairment of suppression of 27 eosinophilia and DC infiltration into the bronchial-alveolar fluid (BALF) and lungs ( Fig. 3 l, m, Extended Data Fig.   28 3m, n), and increased OVA-specific IgG1 levels in OVA-fed S.v. group compared to N.I. mice (Fig. 3n) were even more regionally-restricted in Taconic mice harbouring SFB through parental transmission (Extended Data 6 Fig. 4c, d ), suggesting that recent SFB colonization leads to transient, yet mild SFB dysbiosis in the duodenum and 7 jejunum (Extended Data Fig. 4e, f) . Because TH17 polarization was concentrated in LNs draining the distal segments 8 of the intestine, we anticipated that surgical removal of the ileal and cecal mLNs (I and C1 in Fig. 1h ) would abrogate 9 SFB-specific TH17 responses. Removal of ileal-and cecal-mLNs did not result in evident lymphatic rerouting of 10 antigen and migratory DCs to alternate mLNs, as indicated by fast green injection into the intestinal lymphatics
11
(Extended Data Fig. 4g ). However, distal mLN removal led to ectopic seeding by 7B8tg cells in D-, J-and ascending
12
C-mLNs (C2 in Fig. 1h ) and pronounced RORγt + cell generation ( Fig. 4d-f 
6
Our data uncover a mechanism by which the intestinal immune system simultaneously handles regulatory versus pro-7 inflammatory responses: by anatomical segregation of these reactions into different, functionally specialized mLNs.
8
The efficient drainage of dietary antigens into tolerance-promoting lymph nodes associated to the proximal intestine 
23
Technologies. For cytokine analysis in T cells, cells were incubated for 3.5 h in RPMI with 10% FBS, Brefeldin A
24
(0.5 µg ml -1 , Sigma B7651), ionomycin (0.5 µg ml -1 , Sigma I0634), and phorbol 12-myristate 13acetate (100 ng ml -25 1 , Sigma P8139), for cytokines in dendritic cells, cells were incubated for 6h in RPMI with 10% FBS and GolgiPlug
26
(1 to 1000, BD Biosciences 555029). Cell populations were stained with Aqua in PBS, followed by incubation with
27
Fc block and antibodies against the indicated cell surface markers in FACS buffer (PBS, 1% BSA, 10 mM EDTA, vein. Lymph was collected from the thoracic duct under isoflurane anaesthesia using a custom-made glass needle
10
(Micropipette puller, Sutter Instrument). Dissected organs were weighed prior to lysis by mechanical disruption in 11 0.5 ml hypertonic lysis buffer with 1% Triton-X 100, the lysate mixed with 7 ml Ultima Gold scintillation cocktail
12
(Perkin Elmer) and accumulation of radioactivity measured on a scintillation counter. Input radioactivity was 13 estimated by counting 10 % of the gavaged material.
15
Segmentation of mesenteric lymph nodes. Mesenteric lymph nodes draining intestinal segments were determined
16
anatomically by following the lymphatic vessels connecting the colon, ileum and jejunum to their lymph nodes.
17
Duodenal lymph nodes were revealed by gavaging 100 µl of olive oil (Sigma) and determining the most stomach- 
26
Lymphocyte and APC isolation from small and large intestine. Intestines were separated from mesentery, and
27
Peyer's Patches (small intestine) and feces were removed. For segmentation of the small intestine, the upper 25% of 28 the small intestine were taken as duodenum, the next 50% as jejunum and the last 25% as ileum. The cecum was on a Qubit fluorometer (Thermo Fisher), all samples were adjusted to 0.1 ng/µl with ddH2O, and 2.5 µl cDNA were 31 subjected to Nextera XT DNA Library preparation (Illumina) using a Nextera XT Index Kit (Illumina, FC-131-1002) 32 and according to the manufacturer's protocol, except that all volumes were used at 0.5 x of the indicated volumes.
33
Sample quality was again verified by Bioanalyzer, sample concentrations measured on the Qubit fluorometer and 34 adjusted to a concentration of 4.54 ng/ µl. All samples were pooled at equal contribution and run in multiple lanes.
35
Sequencing was performed using 75 base single-end reading on a NextSeq instrument (Illumina). placed into a beaker with water at 28 °C. The hatching larvae were collected over 4 days and the cycle re-initiated.
32
Mice were infected subcutaneously with 700 larvae/ mouse. Adult worm load was assessed in total epithelial scrapes 33 of the gut. anesthetized by i.p. injection of 0.35 ml of 2.5% avertin (Sigma), the trachea was cannulated and lungs were lavaged 9 once with 0.5 ml and then 1.0 ml PBS. Total BAL cells were counted after erythrocyte lysis and stained for FACS 10 analysis. Lungs were perfused via the right ventricle with 10 ml saline to wash out residual blood. alba. To expose the ileal and cecal lymph nodes, the cecum was gently pulled out using cotton tipped applicators 1 soaked in saline. Lymph nodes were removed by holding onto the lymph node with tweezers and gently pulling it 2 while slowly and closely cutting around the node with microsurgical scissors, such that no bleeding occurred. For 3 sham operation the cecum was pulled out and the lymph nodes exposed for 2 min. The cecum was then placed back 4 into its original position and the peritoneal cavity filled with 0.5 ml pre-warmed saline. The peritoneal muscles were 5 aligned and sutured using absorbable suture (PDS*II, Ethicon), the skin closed with autoclips (Ken Scientific Corp.),
6
and the wound covered with Triple Antibiotic Ointment (Honeywell Safety Products, USA). Mice were allowed to 7 fully awake in a cage placed on a heat mat. The following day mice were monitored for agility and passing stool.
8
Mice were treated with 0.3 mg/kg of buprinex (controlled substance) and 5 mg/kg Meloxicam 24 h after first 9
Meloxicam and for another 3 days every 24 h.
11
Fast green tracing. Mice were anesthetized with isoflurane and their peritoneal cavity exposed. 3-5 µl of 10 % Fast
12
Green in PBS were injected into the muscularis of the terminal ileum using a nano-injection device (Nanoject III,
13
Drummond). Spreading of green colour through the lymphatics was followed until it accumulated in the ileum 14 draining lymph node and until it faded again (sham operated mice) and reached the duodenal lumen via the bile duct,
15
no longer than 15 minutes. The same timing was applied in mice in which ileal and cecal mLNs had been removed,
16
even though the dye never accumulated in a lymph node. 
32
Supplementary Video 2. Duodenal lymphatics (LYVE-1, white) with APCs (CD11c-GFP, red) of 7 week old SPF 33 mouse. Antibody stained solvent cleared tissue followed by light sheet microscopy and 3D software reconstruction.
35
Supplementary Video 3. Duodenal and mLN lymphatics (LYVE-1, white) 9 week old SPF mouse. Antibody 36 stained solvent cleared tissue followed by light sheet microscopy and 3D software reconstruction.
38
Supplementary Video 4. mLN chain to duodenum lymphatics (LYVE-1, white) of 8 week old SPF mouse.
39
Antibody stained solvent cleared tissue followed by light sheet microscopy and 3D software reconstruction.
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Supplementary Video 5. Ileal and mLN lymphatics (LYVE-1, white) of 8 week old SPF mouse. Antibody stained 2 solvent cleared tissue followed by light sheet microscopy and 3D software reconstruction.
4
Supplementary Video 6. mLN lymphatics (LYVE-1, white) with APCs (CD11c-GFP, red) of 8 week old SPF 5 mouse. Antibody stained solvent cleared tissue followed by light sheet microscopy and 3D software reconstruction.
7
Supplementary Video 7. mLN chain lymphatics (LYVE-1, white) with APCs (CD11c-GFP, red) and insulin
8
(green) of 9 week old SPF mouse. Antibody stained solvent cleared tissue followed by light sheet microscopy and 9 3D software reconstruction. Figure 1 . The intestinal lymphatics provide a route for shaping distinct mLN environments. a-h, 3D reconstruction of mouse lymphatics (α-LYVE-1) after solvent clearing (iDISCO+) and light-sheet microscopy of the duodenal (a) and colonic (b) submucosa, villi and submucosa along the intestine (c), duodenal mesenteric collecting vessels (d), the central chain of mLNs (e), the colonic mLN (f), all mLNs and afferent lymphatics coming from the gut (g, h). The following specifics apply: c, 9 week old GF and SPF mice, lymphatics protruding into the villi (lacteals) are pointed out; d, e, arrows denote direction of lymph flow from intestine to mLNs; d, f, g, CD11c was revealed by using Itgax-Venus mice and staining against GFP; g, α-insulin was used to indicate the mLNs embedded in the pancreas. D/Duo=duodenum, whereby D1 portal LNs and D2 distal duodenum mLNs, J/Jej=jejunum, I/Ile=ileum, C1=cecal-colonic mLN, C2=ascending colonic mLN. i-k, Percentage of 3 H-retinol absorption into lymph (L), portal vein serum (PV) or systemic serum (S) (i), indicated gut segment (j) or mLN (k) of mice 3 h after gavage with 1 µCi 3 H -retinol in 100 µl olive oil with or without pre-treatment with 5 µl chylomicron formation inhibitor Pluronic L-81 3h prior to gavage (n= 4 per group). *P < 0.05, **P < 0.01 and ***P < 0.005 (one-tailed t-test or ANOVA). Data representative of two independent experiments. + among CD45.1 + cells in indicated mLNs 60 h post adoptive transfer of 1 x 10 6 naïve CD45.1 + OT-II cells into CD45.2 hosts (n=8) infected with S.v. larvae or N.I. 8 days and gavaged with OVA 48 h and 24 h prior to analysis. Data pooled from two independent experiments. k, Scheme of oral tolerance experimental set-up in S.v. infected mice., l-n, Total eosinophils in bronchoalveolar lavage fluid (BALF) (l), frequency of eosinophils among CD45 + cells in lung tissue (m) and OVA-specific IgG1 levels in serum (n) from mice infected with S.v. or N.I. during antigen feeding (+OVA groups) or no feeding (-OVA groups), at 21 d after first immunization with OVA-alum (k) (n=13 for +OVA groups, n=10 for -OVA groups). Data are pooled from two independent experiments. D=duodenum, whereby D1 portal LNs and D2 distal duodenum mLNs, J=jejunum, I=ileum, C1=cecal-colonic mLN, C2=ascending colonic mLN, C=colon. *P < 0.05, **P < 0.01 and ***P < 0.005 (one-tailed t-test or ANOVA). + 7B8tg cells as depicted in l. n, Summary table of 7B8tg CD4+ T cell fate in mLN and lamina propria upon mLN surgery and SFB peptide administration. D=duodenum, whereby D1 portal LNs and D2 distal duodenum mLNs, J=jejunum, I=ileum, C1=cecal-colonic mLN, C2=ascending colonic mLN, C=colon. *P < 0.05, **P < 0.01 and ***P < 0.005 (one-tailed t-test or ANOVA). a-e, 3D reconstruction of mouse lymphatics (α-LYVE-1) after solvent clearing (iDISCO+) and light sheet microscopy of an ileal Peyer's Patch (a), the duodenal (b) and distal intestine (c) mLNs, the entire mLN chain of SPF and GF mice (d), and the individually dissected mLNs (e). The following specifics apply: b, α-insulin was used to indicate the duodenal mLNs embedded in the pancreas, and liver and pancreas are indicated; d, 9 week old GF and SPF mice. D/Duo=duodenum, whereby D1 portal LNs and D2 distal duodenum mLNs, J/Jej=jejunum, I/Ile=ileum, C1=cecal-colonic mLN, C2=ascending colonic mLN. f, g, Percentage of 3 H-retinol absorption into duodenum (f), or duodenal mLN (g) of mice 8 h after gavage with 1 µCi 3 H -retinol in 100 µl olive oil with or without pre-treatment with 5 µl chylomicron formation inhibitor Pluronic L-81 3h prior to gavage (n= 8-9 per group). Data pooled from two independent experiments with 4-5 animals per group each. h-j, Percentage of 3 H-retinol absorption into systemic plasma (h), indicated intestinal tissue (i) or mLN (j) of GF or SPF mice 1 or 5 h after gavage with 1 µCi 3 H -retinol in 100 µl olive oil (n= 3 per group). Data representative of two independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.005 (one-tailed t-test or ANOVA). g refers to GF ANOVA, s to SPF ANOVA, $ to 1 h time point, # to 5 h time point. + DCs in indicated mLNs of GF and SPF mice (n=4 per group). # indicates fewer than 200 cells were recovered. D=duodenum, whereby D1 portal LNs and D2 distal duodenum mLNs, J=jejunum, I=ileum, C1=cecal-colonic mLN, C2=ascending colonic mLN, C=colon. *P < 0.05, **P < 0.01 and ***P < 0.005 (one-tailed t-test or ANOVA). + cells in lung tissue (n) from mice infected with S.v. or N.I during antigen feeding (+OVA groups) or no feeding (-OVA groups), at 21 d after first immunization with OVA-alum (k) (n=13 for +OVA groups, n=10 for -OVA groups). Data are pooled from two independent experiments. D=duodenum, whereby D1 portal LNs and D2 distal duodenum mLNs, J=jejunum, I=ileum, C1=cecal-colonic mLN, C2=ascending colonic mLN, C=colon. *P < 0.05, **P < 0.01 and ***P < 0.005 (one-tailed t-test or ANOVA). e, f, Relative quantification of SFB specific 16S in luminal contents of indicated gut segment from recently SFB-colonized Jax B6 (e, n=13 per group from 4 independent experiments) or parentally-colonized Taconic (f, n=7 per group from 4 independent experiments) mice after sham or ΔicLN surgery. g, Picture of fast green tracing of ileal lymphatic drainage to the mLNs, 5 min after injection of 3 µl fast green in sham operated (left column, biological triplicates) or ΔicLN (middle and zoomed in right column, biological triplicates) mice 3 weeks after surgery. Red arrows indicate site of injection, jejunal (J), ileal (I) and cecal-colonic (C1) mLNs are indicated. h, i, Total CD45 + counts in ascending colonic mLN of sham or ΔicLN Jax (g, n=9 per group, pooled from 2 independent experiments) or Taconic (i, n=4, representative of two independent experiments) mice. 
RORγt
-(i), and IL17a + among RORγt + Vβ14 + CD45.1 + (j) cells in lamina propria of indicated gut segment 16 days after adoptive transfer of 5000 naïve 7B8tg cells into mice fed SFB peptide and that were subsequently colonized with SFB (n=4, see Fig. 4l ). D=duodenum, whereby D1 portal LNs and D2 distal duodenum mLNs, J=jejunum, I=ileum, C1=cecal-colonic mLN, C2=ascending colonic mLN, C=colon. *P < 0.05, **P < 0.01 and ***P < 0.005 (one-tailed t-test or ANOVA).
